Related Experiment Videos
A functional magnetic resonance imaging study in patients with benign essential blepharospasm
Robert S Baker1, Anders H Andersen, Robert J Morecraft
1Department of Ophthalmology, University of Kentucky College of Medicine, Lexington, USA. rsbmail@pop.uky.edu
Summary
Benign essential blepharospasm (BEB) patients show greater brain activation during blinking compared to controls. These findings suggest a hyperactive cortical circuit in BEB.
Area of Science:
- Neuroscience
- Medical Imaging
Background:
- Benign essential blepharospasm (BEB) is a neurological disorder characterized by involuntary eyelid spasms.
- Understanding the neural underpinnings of BEB is crucial for developing effective treatments.
Purpose of the Study:
- To investigate functional magnetic resonance imaging (fMRI) brain activation patterns induced by blinking in BEB patients.
- To compare these patterns with those of age-matched healthy control subjects.
Main Methods:
- fMRI was used to measure brain activation during spontaneous and voluntary blinking in five BEB patients and five controls.
- Blood oxygen level-dependent (BOLD) images were acquired using a T2-star weighted gradient echo EPI sequence.
- Activation maps were spatially normalized and blurred for group analysis.
Main Results:
- BEB patients exhibited significantly greater activation in the anterior visual cortex, anterior cingulate cortex, motor cortex, thalamus, and cerebellum during blinking compared to controls.
- Both groups showed higher activation during voluntary blinking than spontaneous blinking.
- Specific brain regions involved include the visual cortex, limbic system, motor cortex, cerebellum, and pathways innervating periorbital muscles.
Conclusions:
- The observed brain activation patterns in BEB patients suggest a hyperactive cortical circuit.
- This circuit involves interconnected regions responsible for visual processing, emotional regulation, motor control, and muscle innervation.
- These findings provide insights into the neurobiology of BEB and potential therapeutic targets.